Figure 2 - available via license: Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
Content may be subject to copyright.
26-F continuous-flow resectoscope, working element, cutting and vaporising loop electrodes, and bipolar cord.
Source publication
To evaluate the efficacy and safety of bipolar transurethral resection of the prostate (TURP) in patients with a large prostate (>90 g), as a significant recent modification of TURP is the incorporation of bipolar technology, which uses the same technique as monopolar TURP but with normal saline as the irrigant.Patients and methodsForty patients wi...
Similar publications
Aim:
We compare urethrogram delineation of the caudal aspect of the anastomosis to the recommended guidelines of post prostatectomy radiotherapy.
Background:
Level one evidence has established the indications for, and importance of, adjuvant radiotherapy following radical prostatectomy. Several guidelines have recently addressed delineation of t...
Citations
... The median preoperative prostate volume resected in a study was 57 ml (39 -80.75) [14], in this study, the mean resected prostate volume was 54 ± 12.3 cc [15], and the mean duration of hospitalization was 4.8 days in another study cited by Abdallah MM [16]. The transurethral catheter is usually removed as soon as the urine was clear. ...
... Bipolar TURP differs from traditional monopolar TURP by the use of a double electrode allowing electricity output to the generator, and therefore the use of 0.9% physiological saline instead of glycocol. There is no risk of TURP syndrome [9] [10]. Bipolar transurethral resection has been developed in recent years to minimize current flow absorbed by the patient. ...
... A thermal effect would then be excluded. Some authors compared the results of bipolar TURP with other minimally invasive surgery techniques (HoLeP, Holmium) and open surgery and then concluded that TURP and HoLeP are feasible alternative to resect large BPH, improving the quality of life of the patients [9] [11] [12] [13]. ...
... [1] [9] [13] [24]. We found one study that reported a high number of prostate carcinoma [18]. ...
... The International Prostate Symptom Score (IPSS), evaluated by several authors (see Table 1) as recommended by learned societies (Committee of micturition disorders of the French Association of Urology, the European Association of Urology) has not been evaluated in our series by the fact that out of 70 cases of BPH, 67 patients (95.71%) were admitted in a picture of chronic retention of urine (64 cases) or acute retention of urine (3 cases). Abdallah et al. [12] reported that 30% of their patients presented with urine retention. Kouamé et al. [13] reported 56.6% (n = 53) of urinary bladder retention. ...
Transurethral resection of the prostate (TURP) remains the gold standard treatment for benign prostatic
hyperplasia (BPH). Objective: To report the results of TURP to the Urology Department of Ignace Deen National hospital
Patients and methods: This was a prospective, descriptive study of 2 years 5 months (January 1, 2015 to May 31, 2017), carried
out in the urology department of the Ignace Deen National Hospital. We included 86 patients who benefited from an isolated
TURP or associated with another surgical procedure. Results: TURP accounted for 51.19% of endoscopic surgery and 20.18%
of prostate surgery. The mean age was 69.21 years (48 and 89). The mean total PSA level was 17.7ng / ml. The mean prostate
volume was 54, 22 cm3
(27 and 107). The indication for surgery was dominated by chronic retention of bladder urine (93.02%).
The mean duration of TURP was 41.84 min (28 and 58). Postoperative complications were dominated by orchi-epididymitis
(5.81%) and UVR (4.66%). The mean length of stay was 5.63 days. The histologic types were: benign prostatic hyperplasia
(69.77%), prostatic adenocarcinoma (29.07%) and high grade intraepithelial prostate neoplasia (1.16%). After a mean followup of 2.21 months, the result was good in 95.35% of cases. Conclusion: It offers low morbidity and a good result in almost all
cases.
Background: Benign Prostatic Hyperplasia (BPH) is one of the most common urological diseases seen in aging men. Surgical treatment is recommended for patients unresponsive to medical therapy or those who have developed BPH-related complications. Enucleation procedure distinguished itself as a successful treatment option in large BPH patients, mimics open prostate enucleation, characterized by good surgical efficiency, reduced complications, faster postoperative recovery, similar prostatic tissue ablation capabilities and satisfactory follow-up results compared with the open technique. Objectives: To assess the safety and efficacy of transurethral enucleation of prostate. Methods: Patients aged above 45 years with symptoms of bladder outlet obstruction due to BPH, with maximal urinary flow rate (Qmax) of <15 ml/s, failure to relieve symptoms by medications or acute urinary retention failing at least one trial without catheter or recurrent gross hematuria due to prostatomegaly or upper urinary tract changes due to bladder outlet obstruction due to BPH and patient willing to undergo Transurethral Resection of the Prostate (TUEP) were included in this study. Results: In our study patients aged between 55-90 years were enrolled. Most common presenting complaints were frequency and acute urinary retention. Mean preoperative prostate size was 102.9 ± 10.90g with a range of 84-126 g. Mean operative time was 86.71 ± 5.24 minutes. The mean postoperative ID catheter was 2.1+1.63 days. Postoperative uroflowmetry and International Prostate Symptom Score (IPSS) improved significantly. Conclusion: TUEP represents a promising endoscopic approach in large Benign Prostate Enlargement (BPE) cases, mimics conventional open method of enucleation of the prostate while having all the advantages of a minimally invasive surgery.
Purpose:
To evaluate the clinical curative effect and safety of transurethral (bipolar) plasmakinetic resection of theprostate (PKRP) combined with thulium laser in the treatment of large prostates (> 80mL).
Materials and methods:
From January 2014 to December 2015, 61 patients with benign prostate hyperplasia(BPH) were treated with PKRP combined with thulium laser (n = 25) or PKRP only (n = 36). We retrospectivelyanalyzed the perioperative status of patients status during 3-month follow-up.
Results:
There was no significant difference between the two groups before treatment (P > .05). PKRP combinedwith thulium laser was significantly superior to PKRP in terms of surgical duration, intraoperative blood loss,postoperative bladder washing time, postoperative complications and time of hospital stay (P < .05). There were nosignificant improvements at international prostatic symptom score (IPSS), quality of life (QOL), maximum flowrate (Qmax), and post-void residual (PVR) urine between two groups after 3 months (P > .05).
Conclusion:
PKRP combined with thulium laser is superior than PKRP only for better surgical duration, lessbleeding, higher efficiency and much quicker recovery. It may be a better choice for the treatment of BPH withlarge prostate (> 80mL).
